Most of the EU would like to host the EMA pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Covid Vaccine queue calculator shows when you are expected to receive first and second doses
When will you get the call up for the vaccine? Try our calculator to find out
05:00, 25 APR 2021
A marquee at Preston Bus Station as the vaccine rollout continues (Image: Tony Worrall)
Cut through the noise and get the Lancashire news to your inbox for free - twice dailyInvalid EmailSomething went wrong, please try again later.
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
Coronavirus: EU agency says people should get 2nd dose of AstraZeneca too ctvnews.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ctvnews.ca Daily Mail and Mail on Sunday newspapers.
EMA Says AstraZeneca Vaccine Benefits Increase With Age By Danny KEMP
04/23/21 AT 11:38 AM
The benefits of AstraZeneca s Covid-19 vaccine increase with age and still outweigh the risks for adults despite links to very rare blood clots, the EU s drug regulator said Friday.
Health authorities should also continue to give a second dose of the vaccine, dogged by controversy over the rare but occasionally fatal clots, the European Medicines Agency (EMA) said.
The Amsterdam-based EMA was presenting the findings of a review ordered by the European Commission after concerns that prompted several countries to restrict the AstraZeneca jab s use to older people.
German officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people younger than 60 after more unusual blood clots were reported.
The EMA previously described the clots as “very rare” side effects and said the vaccine’s labels should be modified so doctors and patients are aware of that.
It’s still unclear exactly how frequently the rare blood clots occur. According to data from the U.K., which has administered more AstraZeneca doses than any other country, there were 30 such cases among 18 million inoculations as of late March.
Last month, more than a dozen countries, mostly in Europe, suspended their use of the AstraZeneca shot over the blood clot issue. Most restarted some with age restrictions after the EMA said countries should continue using the vaccine.